Agaricus blazei murill or ABM Mushroom for Cancer
In the seventies, two researchers from Penn State visited the Sao Paulo, Brazil area and discovered the local natives to be extremely healthy with a very low rate of disease. The longevity rate was disproportionately high with people living well over 100. Their secret? It was a simple mushroom, they told the researchers, the ABM mushroom (Agaricus Blazei Murill).
Subsequent studies over the next 25 years have shown the ABM to stimulate the immune system and promote natural mechanisms to battle infectious disease and cancers. ABM stimulates lymphocyte T-cell and Helper T-cell production. The polysaccharide contained in ABM stimulates production of interferon and interleukin that indirectly function to destroy and prevent the proliferation of cancer cells. Additionally, ABM turned out to be a very powerful antiviral agent preventing viruses from entering tissues.
Normally, the polysaccharides found in fungus only affect solid cancers, however the polysaccharide in ABM is effective against Ehrich's ascites carcinoma, sigmoid colonic cancer, ovarian cancer, breast cancer, lung cancer, and liver cancer as well as against solid cancers.
In Japan, ABM, in an injectable form, was found to eliminate all cancerous tumors in 90% of the experimental mice. Additionally, when the mice were fed ABM as a preventative and then injected with a very powerful cancer causing agent (Sarcoma 180), 99.4% of them showed no tumor growth. Conventional medicine has no preventive this powerful.
The studies in Japan showed ABM to be 80% more effective than the world's number one cancer drug, PSK. It contains much higher levels of beta glucans than the other medicinal mushrooms (Maitake, Shiitake, and Reishi) and stimulates NK (Natural Killer) cell activity.
It should be noted that the beta-glucans in these mushrooms work best when taken with vitamin C.
The studies in Japan were so successful that today Japan is now buying over 90% of the available ABM from Brazil.